Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.
2.

Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen.

van Rongen A, Välitalo PAJ, Peeters MYM, Boerma D, Huisman FW, van Ramshorst B, van Dongen EPA, van den Anker JN, Knibbe CAJ.

Clin Pharmacokinet. 2016 Jul;55(7):833-847. doi: 10.1007/s40262-015-0357-0.

3.

Paracetamol pharmacokinetics and metabolism in young women.

Allegaert K, Peeters MY, Beleyn B, Smits A, Kulo A, van Calsteren K, Deprest J, de Hoon J, Knibbe CA.

BMC Anesthesiol. 2015 Nov 13;15:163. doi: 10.1186/s12871-015-0144-3.

4.

Morphine Glucuronidation and Elimination in Intensive Care Patients: A Comparison with Healthy Volunteers.

Ahlers SJ, Välitalo PA, Peeters MY, Gulik Lv, van Dongen EP, Dahan A, Tibboel D, Knibbe CA.

Anesth Analg. 2015 Nov;121(5):1261-73. doi: 10.1213/ANE.0000000000000936.

PMID:
26332855
5.

The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults.

Wang C, Allegaert K, Peeters MY, Tibboel D, Danhof M, Knibbe CA.

Br J Clin Pharmacol. 2014 Jan;77(1):149-59. doi: 10.1111/bcp.12180.

6.

A novel maturation function for clearance of the cytochrome P450 3A substrate midazolam from preterm neonates to adults.

Ince I, de Wildt SN, Wang C, Peeters MY, Burggraaf J, Jacqz-Aigrain E, van den Anker JN, Tibboel D, Danhof M, Knibbe CA.

Clin Pharmacokinet. 2013 Jul;52(7):555-65. doi: 10.1007/s40262-013-0050-0. Erratum in: Clin Pharmacokinet. 2013 Jul;52(7):611. Wang, Chengueng [corrected to Wang, Chenguang].

PMID:
23512668
7.

Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.

Kulo A, Peeters MY, Allegaert K, Smits A, de Hoon J, Verbesselt R, Lewi L, van de Velde M, Knibbe CA.

Br J Clin Pharmacol. 2013 Mar;75(3):850-60. doi: 10.1111/j.1365-2125.2012.04402.x.

8.

Critical illness is a major determinant of midazolam clearance in children aged 1 month to 17 years.

Ince I, de Wildt SN, Peeters MY, Murry DJ, Tibboel D, Danhof M, Knibbe CA.

Ther Drug Monit. 2012 Aug;34(4):381-9. doi: 10.1097/FTD.0b013e31825a4c3a.

PMID:
22660604
9.

A bodyweight-dependent allometric exponent for scaling clearance across the human life-span.

Wang C, Peeters MY, Allegaert K, Blussé van Oud-Alblas HJ, Krekels EH, Tibboel D, Danhof M, Knibbe CA.

Pharm Res. 2012 Jun;29(6):1570-81. doi: 10.1007/s11095-012-0668-x.

10.

Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients.

van Kralingen S, Diepstraten J, Peeters MY, Deneer VH, van Ramshorst B, Wiezer RJ, van Dongen EP, Danhof M, Knibbe CA.

Clin Pharmacokinet. 2011 Nov 1;50(11):739-50. doi: 10.2165/11592890-000000000-00000.

PMID:
21973271
11.

Propofol in (pre)term neonates: consider the extensive interindividual variability in clearance within the neonatal population.

Allegaert K, Peeters MY, Knibbe C.

Paediatr Anaesth. 2011 Feb;21(2):174-5. doi: 10.1111/j.1460-9592.2010.03482.x. No abstract available.

PMID:
21210890
12.

Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model.

Peeters MY, Allegaert K, Blussé van Oud-Alblas HJ, Cella M, Tibboel D, Danhof M, Knibbe CA.

Clin Pharmacokinet. 2010 Apr;49(4):269-75. doi: 10.2165/11319350-000000000-00000.

PMID:
20214410
13.

Pilot study on the influence of liver blood flow and cardiac output on the clearance of propofol in critically ill patients.

Peeters MY, Aarts LP, Boom FA, Bras LJ, Tibboel D, Danhof M, Knibbe CA.

Eur J Clin Pharmacol. 2008 Mar;64(3):329-34. Epub 2007 Nov 13.

PMID:
17994316
14.

Inter-individual variability in propofol pharmacokinetics in preterm and term neonates.

Allegaert K, Peeters MY, Verbesselt R, Tibboel D, Naulaers G, de Hoon JN, Knibbe CA.

Br J Anaesth. 2007 Dec;99(6):864-70. Epub 2007 Oct 26.

15.

Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients.

Peeters MY, Bras LJ, DeJongh J, Wesselink RM, Aarts LP, Danhof M, Knibbe CA.

Clin Pharmacol Ther. 2008 Mar;83(3):443-51. Epub 2007 Aug 8.

PMID:
17687274
16.

Gas chromatography-mass spectrometric assay for propofol in cerebrospinal fluid of traumatic brain patients.

Peeters MY, Kuiper H, Greijdanus B, van der Naalt J, Knibbe CA, Uges DR.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):635-9. Epub 2007 Jan 10.

PMID:
17239666
17.

Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery.

Peeters MY, Prins SA, Knibbe CA, Dejongh J, Mathôt RA, Warris C, van Schaik RH, Tibboel D, Danhof M.

Anesthesiology. 2006 Dec;105(6):1135-46.

PMID:
17122576
18.

Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery.

Peeters MY, Prins SA, Knibbe CA, DeJongh J, van Schaik RH, van Dijk M, van der Heiden IP, Tibboel D, Danhof M.

Anesthesiology. 2006 Mar;104(3):466-74.

PMID:
16508393
19.

Propofol 6% as sedative in children under 2 years of age following major craniofacial surgery.

Prins SA, Peeters MY, Houmes RJ, van Dijk M, Knibbe CA, Danhof M, Tibboel D.

Br J Anaesth. 2005 May;94(5):630-5. Epub 2005 Mar 11.

Supplemental Content

Loading ...
Support Center